AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
4.120
-0.060 (-1.44%)
At close: Jan 16, 2026, 4:00 PM EST
4.209
+0.089 (2.16%)
After-hours: Jan 16, 2026, 7:59 PM EST
AbCellera Biologics Employees
AbCellera Biologics had 596 employees as of December 31, 2024. The number of employees increased by 10 or 1.71% compared to the previous year.
Employees
596
Change (1Y)
10
Growth (1Y)
1.71%
Revenue / Employee
$59,270
Profits / Employee
-$288,049
Market Cap
1.23B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 596 | 10 | 1.71% |
| Dec 31, 2023 | 586 | 91 | 18.38% |
| Dec 31, 2022 | 495 | 109 | 28.24% |
| Dec 31, 2021 | 386 | 180 | 87.38% |
| Dec 31, 2020 | 206 | 99 | 92.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ABCL News
- 3 days ago - AbCellera Biologics Inc. (ABCL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 5 days ago - AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause - Business Wire
- 4 weeks ago - AbCellera and Bruker Reach Global Settlement of Patent Litigation - Business Wire
- 5 weeks ago - AbCellera to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 - Business Wire
- 5 weeks ago - AbCellera Biologics Inc. (ABCL) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - AbCellera Biologics Inc. (ABCL) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 2 months ago - AbCellera Appoints Dr. Stephen Quake to its Board of Directors - Business Wire
- 2 months ago - AbCellera Biologics Inc. (ABCL) Q3 2025 Earnings Call Transcript - Seeking Alpha